InDex Pharmaceuticals Holding AB (publ)

SSE:INDEX.ST

0.244 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Revenue 10.8340097.5050-65.2870.1840.552000000.0040.0050.0090.0170.0090.0350.010.0350.0290.0260.020.0540.0280.0160.0350.0350.0440.030.0520.050.0640.047
Cost of Revenue 0.2590.3041.561.0890.3880.0270.4099.2840.6299.224.3380.4910.3341.08406.7269.4213.89800.0030.0020.1480.0860.1520.1670.170.3050.3658.2044.8920.7621.1620.297-0.0720.099
Gross Profit 10.575-0.304-1.5696.416-0.388-65.314-0.225-8.732-0.629-9.22-4.338-0.491-0.334-1.080.005-6.717-9.404-3.8890.0350.0070.033-0.119-0.06-0.132-0.113-0.142-0.289-0.33-8.169-4.848-0.732-1.11-0.2470.136-0.052
Gross Profit Ratio 0.976000.98901-1.223-15.81900000-2701-746.333-553.176-432.11110.70.943-4.103-2.308-6.6-2.093-5.071-18.063-9.429-233.4-110.182-24.4-21.346-4.942.125-1.106
Reseach & Development Expenses 00000000000000000000000000000000000
General & Administrative Expenses 00000027.7240.47421.90318.61632.3330.6276.1646.0985.2816.20812.19214.61525.45615.32414.95726.67613.05323.1216.21119.49910.98912.63511.6569.3093.8666.2174.313.8965.398
Selling & Marketing Expenses 00000000000000000000000000000000000
SG&A 25.3685.43641.05422.48741.9339.36527.7240.47421.90318.61632.3330.6276.1646.0985.2816.20812.19214.61525.45615.32414.95726.67613.05323.1216.21119.49910.98912.63511.6569.3093.8666.2174.313.8965.398
Other Expenses 000041.846104.932.9393.2224.1164.4962.6211.5012.8212.9022.4092.6462.4167.0591.8232.3672.2931.7162.0052.7392.4752.9321.9862.4212.2672.2152.032.2872.3782.6862.083
Operating Expenses 25.3685.43639.79822.79141.846104.9330.65943.69626.01923.11234.9542.1288.98597.698.85414.60821.67427.27917.69117.2528.39215.05825.85918.68622.43112.97515.05613.92311.5245.8968.5046.6886.5827.481
Operating Income -14.83-85.74-42.05986.869-44.256-58.216-4.461-21.729-18.871-22.746-28.226-42.619-9.319-10.08-7.685-15.571-24.012-25.563-27.244-17.684-17.217-22.511-15.118-25.991-18.799-22.573-13.264-15.386-22.092-16.372-6.628-9.614-6.935-6.446-7.533
Operating Income Ratio -1.369000.89100.892-24.245-39.36400000-2,520-1,537-1,730.111-1,412.471-2,840.333-778.4-1,768.4-491.914-776.241-581.462-1,299.55-348.13-806.179-829-439.6-631.2-372.091-220.933-184.885-138.7-100.719-160.277
Total Other Income Expenses Net 11.82-19.7784.1243.1142.461.9141.009-0.013-0.016-0.05611.04-0.026-0.029-0.008-0.038-0.019-0.006-0.0580-0.003-0.0046.064-0.005-0.0080.0490.1840.1260.1970.0490.043-0.767-0.858-0.145-0.0730.285
Income Before Tax -3.01-105.518-37.93589.983-41.796-56.302-3.452-21.742-18.887-22.802-28.248-42.645-9.348-10.088-7.723-15.59-24.018-25.621-27.244-17.687-17.221-22.447-15.123-25.999-18.75-22.389-13.138-15.189-22.043-16.329-7.395-10.472-7.08-6.519-7.248
Income Before Tax Ratio -0.278000.92300.862-18.761-39.38800000-2,522-1,544.6-1,732.222-1,412.824-2,846.778-778.4-1,768.7-492.029-774.034-581.654-1,299.95-347.222-799.607-821.125-433.971-629.8-371.114-246.5-201.385-141.6-101.859-154.213
Income Tax Expense 004.1243.114-2.46-1.914-1.0090.0130.0160.05611.062000.04400000006.056000.05-0.1870.2820.3910.109-0.022000.09500.285
Net Income -3.01-105.518-37.93589.983-39.336-54.388-2.443-21.755-18.903-22.802-28.248-42.645-9.348-10.088-7.723-15.59-24.018-25.621-27.244-17.687-17.221-22.447-15.123-25.999-18.75-22.389-13.138-15.189-22.043-16.329-7.395-10.472-7.08-6.519-7.248
Net Income Ratio -0.278000.92300.833-13.277-39.41100000-2,522-1,544.6-1,732.222-1,412.824-2,846.778-778.4-1,768.7-492.029-774.034-581.654-1,299.95-347.222-799.607-821.125-433.971-629.8-371.114-246.5-201.385-141.6-101.859-154.213
EPS -0.006-0.2-0.0710.17-0.074-0.1-0.005-0.041-0.036-0.043-0.05-0.08-0.02-0.044-0.03-0.07-0.1-0.14-0.15-0.098-0.094-0.13-0.091-0.16-0.11-0.13-0.079-0.091-0.13-0.2-0.092-0.13-0.088-0.081-0.09
EPS Diluted -0.006-0.2-0.0710.17-0.074-0.1-0.005-0.04-0.036-0.043-0.05-0.08-0.02-0.044-0.03-0.07-0.1-0.14-0.15-0.098-0.094-0.13-0.091-0.16-0.11-0.13-0.079-0.091-0.13-0.2-0.092-0.13-0.088-0.081-0.09
EBITDA -14.526-85.436-37.63190.287-41.428-55.929-3.297-21.415-18.555-22.429-27.925-42.302-9.002-9.733-7.369-15.233-23.777-24.632-27.241-17.681-17.214-22.452-15.115-25.988-18.746-22.757-12.979-14.992-21.98-16.369-6.614-9.6-6.826-6.422-7.224
EBITDA Ratio -1.341000.92600.857-17.918-38.79500000-2,433.25-1,473.8-1,692.556-1,398.647-2,736.889-778.314-1,768.1-491.829-774.207-581.346-1,299.4-347.148-812.75-811.188-428.343-628-372.023-220.467-184.615-136.52-100.344-153.702